October 8, 2022
Evamist® is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause. Evamist® is the only adjustable dosing spray to help relieve moderate-to-severe hot flashes. See full prescribing information.
Padagis President and CEO, Sharon Kochan, stated “This relaunch demonstrates our commitment to bringing complex, specialized products to patients and customers nationwide who are in search of high quality, affordable specialized healthcare products.”
Padagis is a leading provider of extended topical and other specialty pharmaceuticals to its primary markets of the United States and Israel. Padagis employs over 1,300 people worldwide.